DIADIA0.08%
SPYSPY0.05%
QQQQQQ0.34%
Trending
Top trending tickerSNDKSNDK3.96%
SKHYSKHY3.92%
MUMU2.01%
INTCINTC1.36%
SOXLSOXL5.68%
NBISNBIS0.94%
SOXXSOXX1.86%
AMDAMD0.67%
SOFISOFI0.06%
BEBE12.38%
Top trending tickerSNDKSNDK3.96%
SKHYSKHY3.92%
MUMU2.01%
INTCINTC1.36%
SOXLSOXL5.68%
NBISNBIS0.94%
SOXXSOXX1.86%
AMDAMD0.67%
SOFISOFI0.06%
BEBE12.38%

Feed

News

Sentiment

Earnings

Fundamentals

Info

homeSymbolCRDLnews
Exchange: NASDAQ·Updated 07:34 PM EDT
CRDL logo

CRDLCardiol Therapeutics Inc - Ordinary Shares - Class A

$1.20
$0.045
(3.90%)
Today
Closed $1.20
$0.03
(2.50%)
After Hours
Reported EarningsMay 11
Mkt Cap$138.33M
Vol992,450.00
News
all
press releases
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association
Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association Cardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart Association PR Newswire TORONTO, July 14, 2026 Peer-reviewedJAHA...
PR Newswire
More News
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit
Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit Cardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision Summit PR Newswire TORONTO, July 9, 2026 TORONTO, July 9, 2026 /PRNewswire/ - Cardiol...
PR Newswire
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders PR Newswire TORONTO, June 25, 2026 TORONTO, June 25, 2026 /PRNewswire/ -Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL...
PR Newswire
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT
Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDT PR Newswire TORONTO, June 23, 2026 TORONTO, June 23, 2026 /PRNewswire/ - Cardiol...
PR Newswire
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ
Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQ Cardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright...
PR Newswire
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association
Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart Association Cardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the...
PR Newswire
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address...
PR Newswire
Cardiol Therapeutics (TSE:CRDL) Sets New 1-Year High - Here's Why
Cardiol Therapeutics (TSE:CRDL) Reaches New 52-Week High - Should You Buy...
MarketBeat
Cardiol Therapeutics (TSE:CRDL) Trading Up 7.9% - Here's What Happened
Cardiol Therapeutics (TSE:CRDL) Stock Price Up 7.9% - Should You Buy...
MarketBeat
Cardiol Therapeutics CEO: Phase III MAVERIC Nears Full Enrollment as CardiolRx Shows Myocarditis Promise
Cardiol Therapeutics (NASDAQ:CRDL) is aiming to address inflammation-driven heart disease with therapies the company believes could improve outcomes in conditions that currently have limited or no...
MarketBeat
<
1
2
>

Advertisement|Remove ads.